Recent advances in micro- and nanoscale sensing technologies may help diagnose sepsis early and with greater accuracy.
Graphene-based biosensors incorporated in arrays of microneedles are emerging as an alternative to hypodermic needles and could be the next generation of blood sampling devices.
The first digital CRISPR/Cas‐assisted assay that can detect SARS‐CoV‐2 in under 30 minutes.
Personalized medicine for diseases that affect the central nervous system requires renewed focus on visualising the behaviour of drugs in the brain.
A sensitive blood test for the early diagnosis of Alzheimer’s disease could be possible with nanoparticle arrays.
Recent advanced in nanoparticle-based SERS imaging has led to better diagnoses of diseases like cancer, and improvements in image-guided tumor surgeries.
Canadian researchers create technology that reads cancer biomarker like a blood-sugar monitor.
How can computational modeling help to better understand and predict when the power cells of our gut fail?
Researchers at Lund University hail potential game changer in early diagnosis.
Nanotechnology is poised to revolutionize the diagnosis and treatment of patients with type 1 diabetes.